Osteoclast differentiation and activation

William J. Boyle (), W. Scott Simonet and David L. Lacey
Additional contact information
William J. Boyle: Protein Pathways, Inc.
W. Scott Simonet: Amgen, Inc.
David L. Lacey: Amgen, Inc.

Nature, 2003, vol. 423, issue 6937, 337-342

Abstract: Abstract Osteoclasts are specialized cells derived from the monocyte/macrophage haematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment. Discovery of the RANK signalling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass. Further study of this pathway is providing the molecular basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.

Date: 2003
References: Add references at CitEc
Citations: View citations in EconPapers (10)

Downloads: (external link)
https://www.nature.com/articles/nature01658 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:423:y:2003:i:6937:d:10.1038_nature01658

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature01658

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().